Document Detail


Osteonecrosis of the jaws associated with use of risedronate: report of 2 new cases.
MedLine Citation:
PMID:  17223592     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Use of various bisphosphonates has been associated with the development of osteonecrosis of the jaws (ONJ). At least 865 cases of ONJ attributed to these agents have been reported in the English-language literature. Approximately 96% of these published cases were seen with administration of the intravenous agents pamidronate and zoledronate, whereas only 26 cases have been associated with oral bisphosphonates, 25 of them with alendronate. Only a single case of ONJ associated with the oral bisphosphonate risedronate has been previously cited. We report 2 cases of ONJ attributed to risedronate administration. The patients developed osteonecrosis 15 and 24 months after treatment for osteopenia. A regimen of antibiotics and chlorhexidine mouthrinse resolved the osseous defect in the mandible caused by complete exfoliation of a lingual torus in 1 patient. The other patient required sequestrectomy, repeated courses of antibiotics, surgical debridement, and steroids to promote closure of an oroantral fistula and management of sinusitis after bone grafting and implant placement in the posterior maxilla. A demographic profile of reported oral bisphosphonate users affected by ONJ is also provided. With the millions of patients receiving various oral bisphosphonates for osteopenia and osteoporosis, health care practitioners should be aware of the potential for the onset of osteonecrosis and familiar with its management.
Authors:
John K Brooks; Allen J Gilson; Arnold J Sindler; Steven G Ashman; Kevin G Schwartz; Nikolaos G Nikitakis
Publication Detail:
Type:  Case Reports; Journal Article     Date:  2007-01-12
Journal Detail:
Title:  Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics     Volume:  103     ISSN:  1528-395X     ISO Abbreviation:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod     Publication Date:  2007 Jun 
Date Detail:
Created Date:  2007-05-28     Completed Date:  2007-06-12     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9508562     Medline TA:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod     Country:  United States    
Other Details:
Languages:  eng     Pagination:  780-6     Citation Subset:  D; IM    
Affiliation:
Department of Diagnostic Sciences and Pathology, University of Maryland Dental School, Baltimore, Maryland 21201-1586, USA. oralpath5@comcast.net
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Oral
Aged
Bone Density Conservation Agents / administration & dosage,  adverse effects*
Dental Implantation, Endosseous
Etidronic Acid / administration & dosage,  adverse effects,  analogs & derivatives*
Female
Humans
Jaw Diseases / chemically induced*
Middle Aged
Oroantral Fistula / surgery
Osteonecrosis / chemically induced*
Chemical
Reg. No./Substance:
0/Bone Density Conservation Agents; 105462-24-6/risedronic acid; 2809-21-4/Etidronic Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Invasive cervical resorption: clinical and radiological diagnosis and treatment of 3 cases.
Next Document:  G6PD (AC)n and (CTT)n microsatellites in Mexican Mestizos with common G6PD African variants.